- IN BRIEF
Targeting KRAS with reversible inhibitors
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Nature Reviews Drug Discovery 21, 338 (2022)
doi: https://doi.org/10.1038/d41573-022-00062-w
References
Vasta, J. D. et al. KRAS is vulnerable to reversible switch-II pocket engagement in cells. Nat. Chem. Biol. https://doi.org/10.1038/s41589-022-00985-w (2022)